AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32242395 — intervention group
Group type: COMPARATOR
Intervention: Western Medicine (cetirizine hydrochloride, vitamin C, and vitamin B complex)
Number of subjects: 238
Study 34807286 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous transurethral cystolitholapaxy and TURP
Number of subjects: 100
Study 34807286 — intervention group
Group type: COMPARATOR
Intervention: Transurethral cystolitholapaxy plus medical therapy (tamsulosin plus finasteride)
Number of subjects: 100
Study 32329019 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) administration
Number of subjects: 0
Study 32329019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35098979 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain interventions focused on cardiovascular and lifestyle related risk factors
Number of subjects: 4162
Study 35098979 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 4162
Study 34460937 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated palliative care (IPC)
Number of subjects: 160
Study 34460937 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study 32247061 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular repair (ER)
Number of subjects: 125
Study 32247061 — intervention group
Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 125
Study 32247061 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective treatment
Number of subjects: 125
Study 32247061 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 125
Study 35081771 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative messages
Number of subjects: 1804
Study 35081771 — intervention group
Group type: COMPARATOR
Intervention: Non-narrative messages
Number of subjects: 1804
Study 34287507 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 407
Study 34287507 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone
Number of subjects: 407
Study 34287507 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiemetics
Number of subjects: 407
Study 34287507 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 407
Study 34287507 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 407
Study 32763021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.44 mg/kg intravenous dose)
Number of subjects: 30
Study 32763021 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (remifentanil infused to a target plasma concentration of 1.7 ng/mL)
Number of subjects: 30
Study 34545986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 18
Study 33600538 — intervention group
Group type: EXPERIMENTAL
Intervention: Conus interface implants
Number of subjects: 141
Study 33600538 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat-to-flat interface implants
Number of subjects: 141
Study 33600538 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switched interface implants
Number of subjects: 141
Study 33600538 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 141
Study 35539004 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-simulation group (2021)
Number of subjects: 289
Study 35539004 — intervention group
Group type: COMPARATOR
Intervention: Pre-simulation group (2021)
Number of subjects: 289
Study 35539004 — intervention group
Group type: COMPARATOR
Intervention: Pre-simulation group (2020)
Number of subjects: 289
Study 35539004 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-simulation group (2020)
Number of subjects: 289
Study 35539004 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (2021)
Number of subjects: 289
Study 35539004 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall assessment by learners
Number of subjects: 289
Study 32061356 — intervention group
Group type: EXPERIMENTAL
Intervention: CASS system
Number of subjects: 67
Study 32061356 — intervention group
Group type: COMPARATOR
Intervention: Conventional SP approach
Number of subjects: 67
Study 35589608 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) minced and mixed with orabase
Number of subjects: 16
Study 35589608 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% mixed with orabase (Control)
Number of subjects: 16
Study 33707304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) focusing on weight loss through decreased caloric intake and increased physical activity for 10 years.
Number of subjects: 5145
Study 33707304 — intervention group
Group type: COMPARATOR
Intervention: Control condition of diabetes support and education for 10 years.
Number of subjects: 5145
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) at six months postpartum
Number of subjects: 300
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational age
Number of subjects: 300
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Receipt of information about body shape
Number of subjects: 300
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse’s views on the shape of a woman’s body
Number of subjects: 300
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Mode of delivery
Number of subjects: 300
Study 33402110 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression analysis
Number of subjects: 300
Study 32515058 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognition Interaction Training (SCIT)
Number of subjects: 120
Study 32515058 — intervention group
Group type: COMPARATOR
Intervention: Befriending Therapy (BT)
Number of subjects: 120
Study 35413932 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of umbilical cord-derived Wharton’s jelly mesenchymal stromal cells (WJ-MSCs)
Number of subjects: 60
Study 35413932 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose of umbilical cord-derived Wharton’s jelly mesenchymal stromal cells (WJ-MSCs)
Number of subjects: 60
Study 35413932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32392381 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (two educational peer-group sessions and four individual infant observation sessions)
Number of subjects: 42
Study 32392381 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (no educational or infant observation sessions)
Number of subjects: 42
Study 32184252 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula with 2 HMOs (2'-fucosyllactose and lacto-N-neotetraose)
Number of subjects: 156
Study 32184252 — intervention group
Group type: COMPARATOR
Intervention: Infant formula (control)
Number of subjects: 156
Study 32184252 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfed infants (BF)
Number of subjects: 156
Study 32184252 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula-fed infants with FCT BiH at 3 months
Number of subjects: 156
Study 35765084 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy (30-min Armguider robot-assisted therapy, 5 days a week for 6 weeks)
Number of subjects: 86
Study 35765084 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (6 weeks)
Number of subjects: 86
Study 35765084 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy
Number of subjects: 86
Study 35765084 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 86
Study 34196965 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block
Number of subjects: 60
Study 34196965 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 60
Study 32278266 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective contraceptive method after October 2014
Number of subjects: 82
Study 32278266 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-label prescription after 2018
Number of subjects: 82
Study 32278266 — intervention group
Group type: COMPARATOR
Intervention: Under indication prescription
Number of subjects: 82
Study 35812821 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE)
Number of subjects: 0
Study 35812821 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 0
Study 33103326 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Group (VRG)
Number of subjects: 48
Study 33103326 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 48
Study 33103326 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Mobilization Group (EMG)
Number of subjects: 48
Study 32264949 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch group
Number of subjects: 68
Study 32264949 — intervention group
Group type: COMPARATOR
Intervention: Non‐patch group
Number of subjects: 68
Study 32264949 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study 35798514 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) for at least 4 hours
Number of subjects: 240
Study 35798514 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive positive pressure ventilation (NIPPV) for at least 4 hours
Number of subjects: 240
Study 33484510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyriax approach (Group A) - deep transverse friction and Mill's manipulation
Number of subjects: 60
Study 33484510 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan mobilisation with movement techniques (Group B)
Number of subjects: 60
Study 33484510 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 60
Study 32349742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 2400 mg daily for 1 year
Number of subjects: 104
Study 32349742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 36014943 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week resistance training program (3 sessions per week, 60 minutes each)
Number of subjects: 764
Study 33077136 — intervention group
Group type: EXPERIMENTAL
Intervention: IPC + HA
Number of subjects: 29
Study 33077136 — intervention group
Group type: EXPERIMENTAL
Intervention: HA
Number of subjects: 29
Study 33077136 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 29
Study 35535050 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant/Dexamethasone (A/D)
Number of subjects: 90
Study 35535050 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine/Dexamethasone (M/D)
Number of subjects: 90
Study 35535050 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (D)
Number of subjects: 90
Study 34742233 — intervention group
Group type: EXPERIMENTAL
Intervention: CGA-based care by a geriatric mobile team (GerMoT)
Number of subjects: 33
Study 34742233 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study 34550862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound therapy (ST) with virtual reality (VR) stimuli
Number of subjects: 20
Study 34550862 — intervention group
Group type: COMPARATOR
Intervention: Sound therapy (ST) alone
Number of subjects: 20
Study 36775519 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) + Core-stabilization exercises (CSE)
Number of subjects: 35
Study 36775519 — intervention group
Group type: EXPERIMENTAL
Intervention: Core-stabilization exercises (CSE)
Number of subjects: 35
Study 36775519 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) only
Number of subjects: 35
Study 33635871 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management policy for pregnant individuals
Number of subjects: 19
Study 33635871 — intervention group
Group type: EXPERIMENTAL
Intervention: Job adjustments
Number of subjects: 19
Study 33635871 — intervention group
Group type: EXPERIMENTAL
Intervention: Everyday management practices
Number of subjects: 19
Study 33635871 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace culture
Number of subjects: 19
Study 33635871 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic analysis of focus group interviews
Number of subjects: 19
Study 32673652 — intervention group
Group type: EXPERIMENTAL
Intervention: Positional Release Technique (PRT)
Number of subjects: 32
Study 32673652 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRT)
Number of subjects: 32
Study 35835265 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational regimen to increase and maintain plasma potassium (p-K) at high-normal levels (4.5-5.0 mmol/l)
Number of subjects: 1000
Study 35835265 — intervention group
Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 1000
Study 34410568 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 59
Study 34410568 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 59
Study 33736617 — intervention group
Group type: EXPERIMENTAL
Intervention: Group meta-cognitive therapy
Number of subjects: 24
Study 33736617 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 24
Study 35021194 — intervention group
Group type: EXPERIMENTAL
Intervention: Green-MED diet (Mankai 100 g/d, green tea 3-4 cups/d, +800 mg/d polyphenols)
Number of subjects: 284
Study 35021194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED) (28 g walnuts/d, +440 mg/d polyphenols)
Number of subjects: 284
Study 35021194 — intervention group
Group type: COMPARATOR
Intervention: Healthy dietary guidelines (HDG)
Number of subjects: 284
Study 33511699 — intervention group
Group type: EXPERIMENTAL
Intervention: ImageJ RGB processing system
Number of subjects: 19
Study 33511699 — intervention group
Group type: EXPERIMENTAL
Intervention: ImageJ RGB2 processing system
Number of subjects: 19
Study 33511699 — intervention group
Group type: EXPERIMENTAL
Intervention: ImageJ HSB processing system
Number of subjects: 19
Study 33511699 — intervention group
Group type: COMPARATOR
Intervention: Direct visual examination by ophthalmologists
Number of subjects: 19
Study 33226139 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 52 weeks (Arm A)
Number of subjects: 49
Study 33226139 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 24 weeks, followed by every 4 weeks for 28 weeks (Arm B)
Number of subjects: 49
Study 33226139 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Arm C)
Number of subjects: 49
Study 33235256 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS, Cerbomed Nemos)
Number of subjects: 15
Study 33235256 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 36247101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling (FSN)
Number of subjects: 60
Study 36247101 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 60
Study 34020312 — intervention group
Group type: EXPERIMENTAL
Intervention: Suubi + Adherence intervention
Number of subjects: 702
Study 32005340 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week internet-based cognitive behavioral therapy (CBT)
Number of subjects: 73
Study 32005340 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 73
Study 33957937 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-therapy Group (RG) - 20 sessions of 45 min each, five days a week for four weeks
Number of subjects: 23
Study 33957937 — intervention group
Group type: COMPARATOR
Intervention: Control-Group (CG) - Conventional upper-limb rehabilitation
Number of subjects: 23
Study 33957937 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-therapy Group (RG)
Number of subjects: 23
Study 33957937 — intervention group
Group type: COMPARATOR
Intervention: Control-Group (CG)
Number of subjects: 23
Study 32174261 — intervention group
Group type: EXPERIMENTAL
Intervention: IPASS intervention group
Number of subjects: 60
Study 32174261 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (control group)
Number of subjects: 60
Study 33771278 — intervention group
Group type: COMPARATOR
Intervention: 4 weeks of standardized outpatient treatment (cognitive behavioral therapy)
Number of subjects: 85
Study 33771278 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 weeks of standardized outpatient treatment (cognitive behavioral therapy)
Number of subjects: 85
Study 33771278 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of treatment (regardless of group assignment)
Number of subjects: 85
Study 33771278 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of sessions attended
Number of subjects: 85
Study 33771278 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of prescribed sessions attended
Number of subjects: 85
Study 32092918 — intervention group
Group type: EXPERIMENTAL
Intervention: MCD (low-energy moderate-carbohydrate diet)
Number of subjects: 60
Study 32092918 — intervention group
Group type: EXPERIMENTAL
Intervention: MixD (low-energy mixed diet)
Number of subjects: 60
Study 32092918 — intervention group
Group type: COMPARATOR
Intervention: CD (conventional diet)
Number of subjects: 60
Study 34856574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotinine exposure (positive urine samples for nicotine)
Number of subjects: 1197
Study 34856574 — intervention group
Group type: EXPERIMENTAL
Intervention: THC-COOH exposure (positive urine samples for cannabis)
Number of subjects: 1197
Study 34856574 — intervention group
Group type: EXPERIMENTAL
Intervention: THC-COOH exposure
Number of subjects: 1197
Study 33880656 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual, unblinded scoring condition
Number of subjects: 0
Study 33880656 — intervention group
Group type: COMPARATOR
Intervention: Randomized, blinded condition
Number of subjects: 0
Study 32485124 — intervention group
Group type: EXPERIMENTAL
Intervention: 150,000 IU of cholecalciferol
Number of subjects: 109
Study 32485124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 36184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified application of COOK Cervical Ripening Balloon (CCRB) with uterine balloon filled to 120 mL and vaginal balloon filled to 40 mL, with light traction applied and removed after 12 hours.
Number of subjects: 227
Study 36184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified application of COOK Cervical Ripening Balloon (CCRB)
Number of subjects: 227
Study 36184583 — intervention group
Group type: COMPARATOR
Intervention: Conventional application of COOK Cervical Ripening Balloon (CCRB)
Number of subjects: 227
Study 33835152 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-living standing activity (measured by MoveMonitor+ accelerometer/gyroscope)
Number of subjects: 98
Study 32444264 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic prophylaxis (subcutaneous heparin) plus routine care
Number of subjects: 501
Study 32444264 — intervention group
Group type: COMPARATOR
Intervention: Routine care alone
Number of subjects: 501
Study 35807742 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh blueberry
Number of subjects: 37
Study 35807742 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried blueberry powder
Number of subjects: 37
Study 35807742 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 37
Study 35807742 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh blueberry vs Freeze-dried blueberry powder
Number of subjects: 37
Study 35807742 — intervention group
Group type: COMPARATOR
Intervention: Fresh blueberry, Freeze-dried blueberry powder, Control
Number of subjects: 37
Study 33419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-B parametrectomy
Number of subjects: 300
Study 33419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-C1 parametrectomy
Number of subjects: 300
Study 33419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-C2 parametrectomy
Number of subjects: 300
Study 33419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous pregnancy
Number of subjects: 300
Study 33419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 300
Study 35428791 — intervention group
Group type: EXPERIMENTAL
Intervention: Erotic film clip (sexual arousal)
Number of subjects: 24
Study 35428791 — intervention group
Group type: EXPERIMENTAL
Intervention: Horror film clip (negative-nonsexual)
Number of subjects: 24
Study 35428791 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports film clip (positive-nonsexual)
Number of subjects: 24
Study 35428791 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual arousal in males
Number of subjects: 24
Study 35428791 — intervention group
Group type: COMPARATOR
Intervention: Neutral film clips
Number of subjects: 24
Study 33550847 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT implantation with guidance of preprocedural coronary angiography (Group 2, n = 120)
Number of subjects: 180
Study 33550847 — intervention group
Group type: COMPARATOR
Intervention: Standard CRT procedure without guidance of selective left coronary angiography (Group 1, n = 60)
Number of subjects: 180
Study 35861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance-guided adaptive radiotherapy (MRgRT)
Number of subjects: 626
Study 35861861 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided external beam radiation therapy (EBRT)
Number of subjects: 626
Study 35861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical prostatectomy (RARP)
Number of subjects: 626
Study 35861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 626
Study 34836116 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered health coaching intervention
Number of subjects: 0
Study 33495158 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based surgical training course over 1 week
Number of subjects: 51
Study 33495158 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention for initial 12 months)
Number of subjects: 51
Study 34481702 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm C (IPV at 14-weeks and 9-months)
Number of subjects: 936
Study 34481702 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm D (IPV at 6-weeks and 9-months)
Number of subjects: 936